Medicine Access @ Point of Care

Managing Editor: Giulio Zuanetti
e-ISSN: 2399-2026
Frequency: 1 Continuous Issue/year

Publication of clinical trials data: a new approach to transparency in the European legislative framework

Elisa Stefanini

Med Access @ point care 2017; 1(1): e98 - e103

DOI: 10.5301/maapoc.0000018

Article Type: REVIEW
OPEN ACCESS
From off-label to repurposed drug in non-oncological rare diseases: definition and state of the art in selected EU countries

Paola Minghetti, Elena P. Lanati, Josie Godfrey, Oriol Solà-Morales, Olivier Wong, Sonia Selletti

Med Access @ point care 2017; 1(1): e87 - e97

DOI: 10.5301/maapoc.0000016

Article Type: RESEARCH @ Point of care
OPEN ACCESS
Medicines counterfeiting in Africa: a view from Zimbabwe

Shingai D. Gwatidzo, Petronella K. Murambinda, Zivanai Makoni

Med Access @ point care 2017; 1(1): e82 - e86

DOI: 10.5301/maapoc.0000017

Article Type: EDITORIAL
OPEN ACCESS
The critical role of the clinical research coordinator for clinical trials: a survey in oncology

Margherita Cinefra, Celeste Cagnazzo, Laura McMahon, Francesca Arizio, Sara Campora, Roberta Camisa, Giuliana Canzanella, Marianna Contu, Paola Frati, Roberta Sottile, Stefania Gori, Giuseppe Procopio, Oriana Nanni

Med Access @ point care 2017; 1(1): e76 - e81

DOI: 10.5301/maapoc.0000015

Article Type: RESEARCH @ POINT OF CARE
OPEN ACCESS
Access to optimal treatment in head and neck cancer: a patient perspective

Chris Curtis

Med Access @ point care 2017; 1(1): e72 - e75

DOI: 10.5301/maapoc.0000014

Article Type: PATIENTS @ POINT OF CARE
OPEN ACCESS

Current Issue

Fighting counterfeit medicines in Europe: the effect on access to medicines

Maarten Van Baelen, Pieter Dylst, Catarina Lopes Pereira, Johan Verhaeghe, Koen Nauwelaerts, Susie Lyddon

Med Access @ point care 2017; 1(1): e49 - e54

DOI: 10.5301/maapoc.0000010

Article Type: POINT OF VIEW
OPEN ACCESS
Alternatives when an authorized medicinal product is not available

Francesca Selmin, Umberto M. Musazzi, Francesco Cilurzo, Paola Minghetti

Med Access @ point care 2017; 1(1): e16 - e21

DOI: 10.5301/maapoc.0000005

Article Type: REVIEW
OPEN ACCESS
Timeline of authorization and reimbursement for oncology drugs in Italy in the last 3 years

Mariangela Prada, Matteo Ruggeri, Carmen Sansone, Dalila De Fazio, Alessia Tettamanti, Matteo Mantovani

Med Access @ point care 2017; 1(1): e29 - e36

DOI: 10.5301/maapoc.0000007

Article Type: RESEARCH @ POINT OF CARE
OPEN ACCESS
From off-label to repurposed drug in non-oncological rare diseases: definition and state of the art in selected EU countries

Paola Minghetti, Elena P. Lanati, Josie Godfrey, Oriol Solà-Morales, Olivier Wong, Sonia Selletti

Med Access @ point care 2017; 1(1): e87 - e97

DOI: 10.5301/maapoc.0000016

Article Type: RESEARCH @ Point of care
OPEN ACCESS
Publication of clinical trials data: a new approach to transparency in the European legislative framework

Elisa Stefanini

Med Access @ point care 2017; 1(1): e98 - e103

DOI: 10.5301/maapoc.0000018

Article Type: REVIEW
OPEN ACCESS

View top ten

Highlights

Orphan Drugs and Rare Diseases Global Congress 2018 Europe

7-8 March 2018 | London (United Kingdom)

World Pharma Pricing & Market Access 2018

20-21 March 2018 | London (United Kingdom)

23rd Congress of the EAHP

21-23 March 2018 | Gothenburg (Sweden)

The clinical Pharmacy Congress

27-28 April 2018 | London (United Kingdom)

View all highlights